INTERLINK Health Services - Facility Spotlight

Please view the "Facility Spotlights" below to learn more about INTERLINK Transplant Network Providers. If you have general questions about these facilities, please contact the hospital directly. If you would like to discuss specific transplant cases with INTERLINK's Director of Transplant Management, please contact Cindy Mathews, RN at (866) 699-9119.

Children's Hospital Boston is a 397-bed comprehensive center for pediatric health care. It is the primary pediatric teaching hospital of Harvard Medical School, where most of the physicians hold faculty appointments. As the largest pediatric medical center in the United States, Children's offers a complete range of health care services for children from 15 weeks gestation through 21 years of age.

The Pediatric Transplant Center at Children's Hospital Boston has a long tradition in solid organ and bone marrow transplantation. Beginning with the pioneering work in kidney transplantation led by Joseph Murray, MD at the Peter Bent Brigham Hospital, his team began kidney transplantation at Children's Hospital Boston in 1971. Since that time, 589 kidney transplants have been performed. Over 150 liver transplants since 1984, 181 heart transplants since 1986, and 57 lung transplants since 1990 have been accomplished. In partnership with Dana-Farber Cancer Institute, the program has performed more than 1,200 stem cell transplants since the program was founded in the 1970s. These transplant programs represent multidisciplinary efforts that bring together medical and surgical experts in each field complimented by support from nursing, psychiatry, social work, and financial counseling professionals.

Heung Bae Kim, MD, (Pediatric Surgeon) along with William Harmon, MD, (Pediatric Nephrologist) lead the Kidney Transplantation Program, which serves all children with renal failure who require either dialysis or a transplant. Transplantation of related living or cadaveric organs compliment the program in end-stage renal disease. Our pediatric kidney transplants have a high rate of success.

Heung Bae Kim, MD, (Transplant Surgeon) and Dr. Maureen Jonas (Pediatric Gastroenterologist) lead the Liver Transplantation Program. Most liver transplants are performed using cadaveric whole or reduced-size organs, but related living transplantation and split-liver transplantation are also offered. In some cases, liver transplantation is occasionally done in combination with transplantation of other organs, such as intestines or kidneys.

Craig Lillehei, MD, (Pediatric Surgeon) and Gary Visner, DO, MD, (Pediatric Pulmonologist) lead the Lung Transplantation Program. End-stage pulmonary disease in the pediatric patient may take several forms, but the patient who most often receives a transplant is a child with end stage pulmonary disease secondary to cystic fibrosis. Single-lung, partial-lung, double-lung, and heart-lung transplantation is offered, and although the majority of patients receive cadaveric organs, selected patients are considered for related living lung transplantation.

Elizabeth D. Blume, MD, (Pediatric Cardiologist) and John E. Mayer, MD, (Pediatric Surgeon) lead the Heart Transplantation Program. The team evaluates potential candidates for heart transplantation, manages pediatric patients with end-stage heart disease awaiting transplant and cares for transplant recipients. Since its inception in 1986, the service has performed more than 110 heart transplants, making it one of the largest pediatric heart transplant programs in the country.

Directed by Leslie E. Lehmann, MD, (Pediatric Oncologist) the Pediatric Stem Cell Transplantation Program provides state-of-the-art care in this highly technological and rapidly evolving field for patients with cancer, non-malignant blood disorders and primary immunodeficiencies. Specialized physicians are constantly reviewing new and evolving approaches to care for vulnerable patients, and changes in patient management strategies are frequently evaluated and implemented. The clinical program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and the National Marrow Donor Program.

●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●

Barnes-Jewish Hospital has a premier reputation in patient care, medical education, research, and community service. The hospital receives more than 270,000 admissions, outpatient, and emergency department visits each year from patients around the world. As an affiliated teaching hospital of Washington University’s School of Medicine, Barnes-Jewish Hospital has a 1,500 plus member medical staff and is fully accredited by the Joint Commission on Accreditation of Healthcare Organizations.

Barnes-Jewish Hospital has been a leader in the field of organ and tissue transplantation since 1963 while consistently maintaining survival rates above the national average. The volume of transplants performed at Barnes-Jewish Hospital and the groundbreaking work achieved within the field assure that its staff of accomplished physicians and support personnel are prepared to treat any complications resulting from transplantation. In addition, patients facing other medical problems, related or unrelated to transplantation, have access to the expertise of national recognized specialists working in Barnes-Jewish Hospital’s centers of clinical excellence.

The transplant program at Barnes-Jewish Hospital is committed to a team approach of personalized and compassionate patient care. The multidisciplinary transplant teams are composed of surgeons, physicians, transplant coordinators, an HLA lab, a transplant pharmacist, dietitians, physical therapists, social workers, financial specialists, psychologists, chaplains, and others.

Combining the efforts of medicine, surgery, and outstanding support services, the kidney transplant team has significantly reduced the length of a hospital stay, decreased the number of complications, and achieved a dramatically low organ rejection rate. With one of the oldest, most successful kidney transplant programs in the country, Barnes-Jewish Hospital and Washington University School of Medicine remain at the forefront of kidney transplantation. More than 2,000 people have received a kidney transplant at Barnes-Jewish Hospital, where rejection rates are among the lowest in the country.

The Baylor Regional Institute (BRTI) is the integration of transplantation services at Baylor University Medical Center (Dallas) and Baylor All Saints Medical Center at Fort Worth. BRTI oversees and guides the quality, innovation, and skill that Baylor is known for in the field of transplantation. Baylor is one of only a few hospitals in the nation whose physicians and surgeons on the medical staff have performed more than 7,000 transplants.

A large number of treatment protocols used in transplantation started here. Many of the most widely used drugs for treating organ rejection were pioneered at Baylor. In collaboration with UCLA, Baylor has produced the prevailing textbook for liver transplant procedures. Baylor surgeons have performed more than 2,500 liver transplants ranking it among the largest and most experienced in the world. Most importantly, patient survival rates have consistently exceeded the national average as well as the expected survival for a center taking the most difficult of cases.

Baylor’s kidney transplant program is one of the largest in Texas and patient outcomes exceed the national average as reported by the United Network for Organ Sharing (UNOS). Baylor actively participates in efforts to increase living donor awareness and almost 50% of our transplants utilize living donors.

Since 1996, Baylor has achieved a 90% or higher one-year survival rate for heart transplant recipients. These results attest to the quality care that is delivered by the team. Baylor has an active program utilizing left ventricular assist devices (LVAD) allowing patients to wait for a transplant at home thereby greatly improving their quality of life.

Baylor’s Congestive Heart Failure program focuses on educating the patient about nutrition, lifestyle and the importance of the patient’s role in therapy. A proven success, the program has achieved dramatic results in a short period of time. In a 13-month study of 41 patients, the hospital readmission rate dropped from 18.9% (national average is 20%) to 2.4%.

Physicians with Baylor’s stem cell program have performed more than 3,000 transplants, including autologous, allogeneic-related and allogeneic-unrelated donors ranking it among the largest centers in the nation. It was among the first six centers to receive FACT accreditation in 1998, and continued to renew this accreditation in 2001 and 2005. Collaborating with other top centers in the country, research is at the forefront of the program offering patients the latest treatment options. Baylor also participates as a study center as a part of the National Institutes of Health Clinical Trials Network.

A deep dedication to research, and clinical application of that research, has been integral to Baylor’s transplant program from the beginning. This ongoing research along with quality patient care has built a solid foundation and successful track record in every organ specialty – liver, kidney, heart, lung, pancreas, and stem cell.

INTERLINK Accredited Programs

This is a special place - a place that has cared for the sickest, most seriously injured children for more than 100 years. From a modest beginning in a two-story house, Childrens Hospital Los Angeles has become one of the world's top pediatric facilities, acknowledged throughout the United States and around the world for its leadership in pediatric and adolescent health.

The physicians, nurses and other caregivers at Childrens Hospital Los Angeles - and those who support them - are committed to helping children and adolescents lead healthier, happier lives today. They are dedicated to finding the best means to diagnose, treat, and cure pediatric disease and to promote child health tomorrow. They improve the lives of children every day - children who are "…living proof that what we're doing is making a world of difference".

Most know Childrens Hospital Los Angeles for its superb patient care. But, it also is one of America’s premier teaching hospitals, affiliated with the Keck School of Medicine of the University of Southern California for more than 72 years, and it is a national leader in pediatric research.

Childrens Hospital Los Angeles treats nearly 58,000 patients a year in its Emergency Department. It admits more than 10,800 children a year to the hospital, with almost 50-percent of those admissions children under four years of age. There are more than 287,000 visits a year to its 29 outpatient clinics; nearly 5,000 visits at community sites through its Division of Adolescent Medicine. Childrens Hospital Los Angeles is able to offer the optimum in multidisciplinary care, with 33 pediatric subspecialties and dozens of special services for children and families.

Training programs at Childrens Hospital Los Angeles include 250 medical students, 83 full-time residents and 71 fellows, who collectively reflect the diversity of the patient population and the city of Los Angeles.

Today, physician-scientists at Childrens Hospital Los Angeles address the most vexing pediatric medical problems and discover important new therapies for children everywhere, including advances in cancer care, gene transfer, stem cell and organ transplantation and diabetes. The Saban Research Institute is among the largest and most productive pediatric research facilities in the United States, with 89 investigators at work on 230 laboratory studies, clinical trials, and community-based research and health services. It is one of the few free-standing research centers in the nation to combine scientific laboratory inquiry with patient clinical care – dedicated exclusively to children - and its base of knowledge is widely considered to be among the best in pediatric medicine.

Children’s Hospital of Pittsburgh is devoted solely to the care of infants, children, and young adults. Known for excellence in pediatric care, education and research, Children’s Hospital consistently ranks as one of the top ten pediatric hospitals in the country by Child magazine and one of the best children’s hospitals in America by U.S. News and World Report.

Children’s was the first hospital in the United States to establish a pediatric transplant center under the stewardship of Thomas E. Starzl, MD, PhD. Children’s Hospital continues to be a world leader in transplantation and research and has performed more pediatric transplants than any other pediatric center. In 2006, Children’s is proud to celebrate 25 years of transforming the lives of pediatric transplant patients.

World’s Highest Survival Rates
Using the very latest diagnostic techniques, drug therapies, and surgical procedures, Children’s Hospital of Pittsburgh achieves patient survival rates that are among the highest in the world. Our transplantation program includes the following:

The staff at Children’s Hospital of Pittsburgh understands the physical and emotional toll of organ transplantation for patients and families. For this reason, Children’s Hospital offers a range of ancillary services that include social workers, psychologists, physical and occupational therapists and financial counselors. In addition, Children’s Hospital sponsors summer camps that give pediatric transplant patients a chance to spend a weekend outdoors with other transplant recipients.

For questions about the pediatric transplantation program at Children’s Hospital of Pittsburgh, call 412-692-7337 and ask for the transplant coordinator.

Inova Health System began in 1956 in response to Northern Virginia's growing need for convenient, accessible health care. Known as the Fairfax Hospital Association, the not-for-profit health care system grew from one hospital to a network of hospitals and other health care services.

The Inova Transplant Center at Inova Fairfax Hospital is the most active transplant program in the Washington, DC, area. The Transplant Center is proud to offer a full spectrum of transplant services including kidney, pancreas, liver, lung, heart, and bone marrow. As the area’s most comprehensive transplant center, they offer the unique blend of cutting edge technology with traditional values of caring for and about people.

The Transplant Center staff uses a multidisciplinary support system to integrate every aspect of a patient's care before, during, and following the transplant procedure. The transplant team at the Inova Transplant Center consists of everyone from doctors to dietitians, that all work together to help provide the best possible care for our patients. All the needs of the patient and their families are met through the close collaboration of transplant center specialists. A strong emphasis is placed on family involvement, quality-of-life issues, and the cost-effective delivery of care throughout the transplant process.

The Inova Transplant Center performed Washington’s first heart transplant in 1986 and has accomplished many other firsts since then. People from throughout the region come to the Inova Transplant Center when transplant is their last and only life-saving option. Call (800) 358-8831 for patient referral or other information.

The University of Miami/Jackson Memorial Medical Center (UM/Jackson) ranks among the top U.S. medical centers for total solid organ transplantation. Our teams perform over 400 life-saving adult and pediatric transplants each year, including many international patients.

The UM/Jackson Transplant Center welcomes all patients needing transplants, regardless of the severity or complexity of an individual's condition. We offer excellent care from a multidisciplinary team, state-of-the-art treatments, the latest immunosuppressive therapies, and all the resources of South Florida's largest academic medical center. Support from our transplant team is available 24 hours a day, seven days a week.

The UM/Jackson Transplant Center is a member of the United Network for Organ Sharing (UNOS), the central U.S. agency responsible for equitable allocation of organs. This affiliation offers our patients with the best opportunities to receive new organs and enjoy a longer and better quality of life.

The UM/Jackson Transplant Center currently has the following fully credentialed programs:

For additional information on any of these programs, please call UM/Jackson at (305) 355-5000.

Lucile Packard Children’s Hospital (LPCH) is a world-class, non-profit hospital devoted entirely to the care of babies, children, adolescents and expectant mothers. Since LPCH is a teaching hospital, our programs train the next generation of physicians and pursue research to advance the science of transplantation and improve patient outcome. Because our program is a leader in teaching and research, our patients receive the most advanced care available.

LPCH transplant teams are recognized for their surgical innovations, high survival rates, success with very small or sick newborns and efforts to minimize post-transplant rejection and adverse effects of medication regimens. Our teams take a family-centered approach to care for its patients. We work to provide comprehensive treatment that respects a family’s unique needs, preferences and skills.

The LPCH health care team works with the patient and family before, during and after the transplant. A multidisciplinary group of clinicians, social workers, financial counselors and support staff all work together to describe the treatment plan and any changes that may be necessary, offer support, answer questions and provide referrals to outside agencies. The goal of our transplant teams is to ensure the patient and family’s physical, social and emotional needs are met to create the best possible outcome.

Kovler Organ Transplantation Center

The Kovler Organ Transplantation Center at Northwestern Memorial Hospital has been a leader in transplantation services since 1964 and is recognized by many to be the regional leader in research, innovation and patient care. Transplant surgeons at Northwestern Memorial transplant more than 400 organs each year which ranks the program among the nation's leaders in both the number of transplants performed and patient outcomes. According to the United Network for Organ Sharing and US Transplant Scientific Registry, Northwestern Memorial ranks in the top 10^th percentile in the number of kidney, pancreas and liver transplants among the 230 organ transplant centers in the United States. Additionally, Northwestern Memorial is one of just a few centers pioneering in islet cell and intestinal transplants.

The Kovler Organ Transplantation Center at Northwestern Memorial Hospital offers comprehensive, compassionate care throughout the transplant process.

If you have any questions regarding our transplant program, call (877) 666-8282.

Since its inception in 1984, the Ochsner Multi-Organ Transplant Center has performed more than 2,400 life-saving heart, lung, liver, kidney, and pancreas transplants, making it the Gulf South’s leading transplant center. For more than 50 years, the Ochsner name has been synonymous with high quality, multi-specialty care, and this tradition provides a strong foundation for the Multi-Organ Transplant Center. Innovation and dedication to excellence remain Ochsner’s hallmarks. By teaming an expert surgical staff with a comprehensive corps of multi-disciplinary transplant physicians and support specialists, the Ochsner Multi-Organ Transplant Center is poised to remain a leader in transplantation well into the new millennium.

Pre- and post-transplant care are provided at Ochsner Foundation Hospital, on a floor where nurses are trained to take care of transplant patients. The team strives to lessen the stresses of transplantation by delivering excellent medical care to transplant patients and addressing the emotional, financial, and practical support issues so often faced by transplant patients and their families.

The Ochsner Clinic Foundation has the only Medicare-approved heart and lung transplant programs in the Gulf South and has one of the top ten largest liver programs in the U.S.

An international leader in oncology since 1898, Roswell Park Cancer Institute (RPCI), located in Buffalo, NY, is well-known for the strengths of its translational research, multidisciplinary oncology teams, and compassionate staff.

Throughout the 20th century, RPCI led the fight against cancer with the nation’s first chemotherapy program, breakthrough discoveries such as the prostate specific antigen (PSA), and the development of photodynamic therapy (PDT). Continuing in the 21st century is RPCI’s unconditional commitment to excellence in each of its mission areas: clinical care, research, prevention, and education. A nearly seamless interface of scientific inquiry and clinical application – and an aggressive clinical trials program – affords RPCI patients access to the newest cancer diagnostics, technology, and treatments.

Consistently rated in the top tier of quality specialty centers, RPCI brings innovative therapies to patients from across the region and around the world. Its multidisciplinary clinics unite oncologists, surgeons, radiation therapists, and other specialists in highly coordinated teams centered on specific malignant diseases. The effectiveness of this integrated care is paralleled by the efficiency of its leading edge therapies.

Approximately 60% of RPCI’s 25-acre campus has undergone major renovation or has been newly built since 1998. A new Center for Genetics and Pharmacology will open in Spring 2006.

RPCI ranks among the top 1% of cancer centers and teaching hospitals nationally for patient satisfaction with physician services and overall care.

RPCI is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York and is a member of the prestigious National Comprehensive Cancer Network. Its Blood/Marrow Transplant Program, which emphasizes clinical trial development, is accredited by the National Marrow Donor Program as an Apheresis, Collection, and Transplant Center, and by the Foundation for the Accreditation of Cellular Therapy. Approximately 85-100 blood and marrow transplants are performed at RPCI each year.

INTERLINK Accredited Programs

The Stem Cell Transplantation Program at St. Jude is one of the largest pediatric programs in the world, having performed a total of more than 1,000 transplants since 1982, including 150 transplants in the last year. Patients include newborns, infants, children, adolescents, and young adults, who have a malignant or nonmalignant life-threatening disorder that is treatable with a hematopoietic stem cell / bone marrow transplant with autologous cells or allogeneic cells.

Children with life-threatening illnesses who are undergoing hematopoietic stem cell / bone marrow transplant require highly specialized resources and experienced staff, such as are available at St. Jude, to meet their physical, psychological, social, and developmental needs. At St. Jude, a multidisciplinary team of health care professionals provides advanced treatment, and all patients are enrolled on clinical research protocols that are designed to give patients the best possible chances of survival with the fewest possible complications when they undergo the transplantation procedure.

The Transplant Unit at St. Jude is a closed, fourteen-bed unit specifically designed for the care of immunocompromised patients; full facilities for stem cell processing and storage are available in a Human Applications Laboratory on the same floor with offices for the transplant coordinator, clinical nurse specialist, social worker, and a play area operated by Child Life Specialists.

A National Leader in Organ Transplantation
St. Louis Children's Hospital is at the forefront of pediatric organ transplantation in the United States, thanks in part to its close association with Washington University School of Medicine and the neighboring adult transplant center at Barnes-Jewish Hospital. The combination of professional expertise, technical skill and innovative research shared at the three institutions has enabled all to build upon individual successes.

Treating Children and Their Families
From evaluation for transplant through management of the disease to the transplant surgery and vital follow-up care, the needs of the children and the support needs of their families are the common focus of the team. Every pediatric transplant candidate and his or her family receive individualized attention to help prepare physically, emotionally and financially for the major issues involved in organ transplantation.

Our Central Location
Located in the Midwestern United States, St. Louis Children’s Hospital has an important geographic advantage over many other transplant centers. Our central location provides the ability to retrieve organs from virtually anywhere in the United States.

Heart Transplant:
• Performed over 250 pediatric heart transplants. Age range: newborn to 22 years
• ABO incompatible heart transplant option available. This allows transplant of unmatched blood type organ to infants who are medically eligible for this option
• Performed the first Berlin Heart procedure in Missouri. Berlin Heart is a ventricular assist device that is used as a bridge to transplant for pediatric patients who meet criteria for its use.

Liver Transplant/Liver Care Center:
• Second largest transplant volume in the Midwest and top 10 in volume in the nation
• Multiple liver transplant options available: whole liver, segmented/reduced liver, split liver, living donor liver, and combined liver/lung.
• Center of excellence for pediatric liver disease including biliary atresia, liver tumors, metabolic diseases and hepatitis

Lung Transplant:
• Largest pediatric lung transplant experience, having performed more than 300 lung and heart-lung transplants since 1990
• Performed the region’s first living donor lung transplant

Kidney Transplant:
• Graft and patient survival rate well over the national average
• Performed over 130 kidney transplants since 1990, about 50% living donor versus deceased donor

Bone Marrow Transplant:
• FACT approved center
• Children’s Oncology Group approved center
• First hospital in Missouri to develop a comprehensive pediatric Bone Marrow Transplant Program. Our unit is one of a select few pediatric facilities nationwide certified to perform transplants from unrelated donors.
• Perform stem cell transplants from any applicable stem cell source

The University of Texas Southwestern Medical Center at Dallas ranks among the top academic medical centers in the world. Its faculty members – who are responsible for a broad array of groundbreaking biomedical research advances – are respected for their dedication to teaching and training. UT Southwestern’s physicians provide patients with the highest quality of care throughout the medical center’s outpatient clinics and hospitals.

One of those hospitals, St. Paul University Hospital, was founded in 1896 as the first private hospital in Dallas. With more than 100 years of experience in health care in Dallas, St. Paul has built a reputation for excellence in cardiology, emergency medicine, obstetrics/gynecology, oncology, orthopaedics, transplantation, and urology, among other services.

Through the UT Southwestern/St. Paul University Hospital Heart and Lung Program, both faculty and private physicians provide medical and pre- and post-surgical management to patients awaiting, or who have undergone, heart and/or lung transplantation. A multidisciplinary approach enables the program to excel in providing advanced care from physicians, nursing coordinators, social workers, and dietitians.

Physicians in the Heart and Lung Program have performed more than 300 heart transplants since its inception. Survival rates for the first three years following transplantation are among the best in the country, according to data provided by UNOS – 11 percent above the national average. Survival rates for the first year following lung transplantation are 16 percent above the national average, according to UNOS.

In addition to transplantation services, St. Paul University Hospital offers other pulmonary resources, including a pulmonary function laboratory providing expertise in managing cystic fibrosis, pulmonary hypertension, interstitial fibrosis, and pulmonary neuromuscular diseases.

Stanford Hospital & Clinics is known worldwide for advanced patient care provided by its physicians and staff, particularly for the treatment of rare, complex disorders in areas such as cardiac care, cancer treatment, neurology, neurosurgery, obstetrics, surgery, and organ transplants.

Throughout its history, they have pioneered medical advances that save lives and protect against disease. For example, they performed the first successful adult human heart transplant in the country and the first combined heart-lung transplant in the world. As part of the Stanford University Medical Center, Stanford Hospital & Clinics has a close relationship with both the Stanford University School of Medicine, the oldest medical school in the Western United States, and Lucile Packard Children's Hospital, an adjacent pediatric teaching hospital providing general acute and tertiary care. Stanford's ability to provide state-of-the-art care is enhanced by the close collaboration among these entities and their mutual commitment to patient care.

The solid organ programs as Stanford strive for meticulous care and superb results. They apply progressive clinical protocols with regular outcome assessment to meet the needs and expectations of patient, family, and referring physician by providing quality medical care, nursing care, and ancillary support services. Building on Stanford's long-standing history of research in transplant immunology and clinical immunosuppression, the program aims to engender clinical transplantation research. The clinical research focuses on strategies to minimize side effects of chronic immunosuppression and to improve long-term outcomes.

The Blood and Marrow Transplant (BMT) Program at Stanford is committed to outstanding clinical care and research. This commitment, in conjunction with the numerous research resources and comprehensive support services offered at Stanford, assures the best possible outcome for our patients and their families. The intent of the program is curative rather than palliative; the goal is full reintegration of each patient into his/her normal, everyday life. Since the program’s inception in 1986 more than 3,300 adults and children have received blood and marrow transplants at Stanford.

UCSF Medical Center is one of the nation's top 10 hospitals, according to U.S. News & World Report. We are recognized throughout the world as a leader in medicine, known for compassionate and innovative care. And, our more than 900 doctors not only have access to the latest technologies, they are often the doctors who develop them.

UCSF's organ transplant service is one of the largest and most highly regarded in the country. Since its founding in the 1960s, our transplant service has expanded to include excellent programs for kidney, kidney-pancreas, liver, heart, and lung.

UCSF Medical Center is also a leader in blood and bone marrow transplantation for the treatment of a number of blood disorders. Our expert transplant team is comprised of health professionals who care for individuals and their families throughout the transplant process.

UCSF has performed more kidney transplants than any other institution in the world, about 6,000 since 1964. Our program is the second-largest center for living-donor kidney transplants in the country. UCSF is proud of its history providing liver transplants to those in need. 91.42 percent of our patients were alive a year after a liver transplant, compared to the 85.23 percent expected survival rate based on patient characteristics. Our lung transplant staff has performed more than 100 transplants since we started the program in 1991, with an average one-year survival rate of 80 percent compared to a national average one-year survival rate of 70 percent. Since 1989, UCSF has performed combined pancreas-kidney transplants in more than 200 Type 1 diabetic patients. Our one-year success rates are 95 percent for kidneys, 90 percent for pancreases, and 100 percent patient survival.

In partnership with the University of Texas Health Science Center at San Antonio

The Transplant Center at University Hospital, in partnership with The University of Texas Health Science Center at San Antonio has been a pioneering force in organ transplantation for over 20 years.

Since our program’s inception, we have performed over 2,400 kidney, liver and lung transplants. We rank in the top five Transplant Centers in Texas for the number of Transplants performed: #1 for lung transplants and #2 for liver transplants. The Transplant Center consistently achieves patient survival rates above the national average for all three transplantation programs:
One Year Patient Survival Rates:

The pursuit of renewing and extending life through transplantation never ceases. Our research team works continuously to translate the latest bench findings to further enhance transplant patient care.

The Transplant Center Amenities:
• Private patient rooms
• State-of-the-art dedicated transplant unit
• Newly remodeled Transplant Clinic Center
Support Renewed Life - visit www.uhstransplant.com for more information
888-336-9633 / 210-567-5777

The University of Chicago Hospitals is a world leader in transplantation. Since the first human transplant performed there, the center has performed more than 1,500 kidney transplants, 100 pancreas transplants, 500 pediatric and 700 adult liver transplants, 877 autologous stem cell transplants and 330 allogeneic transplants. The University of Chicago Hospitals has the largest and oldest series of living related liver transplant patients in North America.

Organ transplantation began at the University of Chicago. In 1904, a University of Chicago doctor, Alexis Carrel, MD, performed the first animal organ transplant, which earned him the Nobel Prize. Since then, we have been a world leader in organ transplant. University of Chicago has been a pioneer in transplantation with the a series of firsts, including the first successful living-donor liver transplant in the world, the first successful heart-liver-kidney transplant in the world, and the first segmental liver (“reduced size”) and split-liver transplants in the United States.

University of Chicago researchers continue to improve patient care through the evaluation and development of groundbreaking technology, such as an FDA approved clinical trial for islet cell transplantation in patients with Type 1 DM, participation in the NIH multi-center study for the transplantation of liver and kidney patients who are HIV+, developing immunosuppressive therapies that may further control both acute and chronic rejection including NIH sponsored studies in tolerance as well as the immunology of xenograft rejection. Some improvements in the area of Stem Cell Transplant have been the first pediatric stem cell transplant for sickle cell disease, development of new approaches to prevent and treat graft versus host disease, and the study of vaccines to prevent cancer recurrence following allogeneic transplantation.